Using vending machines to distribute naloxone for opioid overdose prevention
Vending machine Naloxone Distribution for Your community (VENDY): Increasing reach and implementation of naloxone distribution
This study is looking at how vending machines can help make naloxone, a lifesaving medication for opioid overdoses, more available in communities that need it most, and it’s designed to make sure these machines work well for everyone.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10873832 on NIH RePORTER |
What this research studies
This research investigates the use of vending machines to distribute naloxone, a medication that can reverse opioid overdoses, particularly in underserved communities. The project aims to engage local stakeholders and refine the program through user-centered design to ensure that the vending machines are accessible and effective. By addressing implementation challenges and focusing on community needs, the research seeks to increase the availability of naloxone where it is most needed. The study will take place in both urban and rural settings to assess the effectiveness of this innovative distribution method.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in underserved areas who are at risk of opioid overdose or have a history of substance use.
Not a fit: Patients who do not reside in or have no connection to the targeted underserved communities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce opioid overdose deaths by improving access to naloxone in high-risk communities.
How similar studies have performed: Similar approaches using vending machines for naloxone distribution have shown success in Europe, indicating potential for effectiveness in the U.S.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Wagner, Nicole Marie — University of Colorado Denver
- Study coordinator: Wagner, Nicole Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.